Cargando…
In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds
[Image: see text] Cytochrome P450 46A1 (CYP46A1) is a central nervous system-specific enzyme, which catalyzes cholesterol 24-hydroxylation. Currently CYP46A1 is being evaluated in a clinical trial for activation by small doses of the anti-HIV drug efavirenz. Eight efavirenz-related compounds were in...
Autores principales: | Mast, Natalia, Verwilst, Peter, Wilkey, Clayton J., Guengerich, F. Peter, Pikuleva, Irina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226586/ https://www.ncbi.nlm.nih.gov/pubmed/31617715 http://dx.doi.org/10.1021/acs.jmedchem.9b01383 |
Ejemplares similares
-
CYP46A1-dependent and independent effects of efavirenz treatment
por: Mast, Natalia, et al.
Publicado: (2020) -
Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1)
por: Mast, Natalia, et al.
Publicado: (2017) -
The normalizing effects of the CYP46A1 activator efavirenz on retinal sterol levels and risk factors for glaucoma in Apoj(−/−) mice
por: El-Darzi, Nicole, et al.
Publicado: (2023) -
Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes
por: Petrov, Alexey M, et al.
Publicado: (2020) -
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications
por: Pikuleva, Irina A., et al.
Publicado: (2021)